HeartBeam, Inc. BEAT
NASDAQ · United States · Health Technology
$0.4350+0.02 (+3.82%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
SANTA CLARA, Calif., September 21, 2026--HeartBeam, Inc. Letter to Shareholders
Moby summary of HeartBeam, Inc.'s Q2 2026 earnings call
HeartBeam Inc (BEAT) progresses its regulatory pathway with a 510(k) pre-submission while expanding commercial agreements and extending its cash runway into 2027.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
SANTA CLARA, Calif., August 13, 2026--HeartBeam Reports Second Quarter 2026 Results
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.